Arvee Laboratories (India) Ltd. (NSE:ARVEE)

Market Cap	1.62B
Revenue (ttm)	381.81M
Net Income (ttm)	21.94M
Shares Out	11.02M
EPS (ttm)	1.99
PE Ratio	74.03
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24
Average Volume	486
Open	145.00
Previous Close	140.57
Day's Range	144.28 - 147.20
52-Week Range	117.05 - 315.00
Beta	0.56
RSI	52.55
Earnings Date	May 28, 2025

About NSE:ARVEE

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India and internationally. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, ...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2012
• Employees: 65
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ARVEE

Financial Performance

In 2023, NSE:ARVEE's revenue was 303.45 million, a decrease of -50.54% compared to the previous year's 613.47 million. Earnings were 10.52 million, a decrease of -74.46%.